<DOC>
	<DOC>NCT00674154</DOC>
	<brief_summary>The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.</brief_summary>
	<brief_title>Effect of Vitamin D Treatment in Primary Hyperparathyroidism</brief_title>
	<detailed_description>The study investigates effects and safety of six months of vitamin D supplementation before and after surgery in primary hyperparathyroidism. Effects are assessed as changes in calcium homeostasis, bone metabolism, quality of life, and muscle strength and function.</detailed_description>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Hyperparathyroidism, Primary</mesh_term>
	<mesh_term>Hypercalcemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>PCaion &gt; 1,30 mmol/l PPTH &gt; 5 pmol/l POH25vitamin D &lt; 80 nmol/l Pcreatinin &gt; 120 mumol/l usage of Etalpha, Mimpara Cancer Sarcoidosis malabsorption pancreatitis alcohol abuse pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Primary hyperparathyroidism</keyword>
	<keyword>hypercalcemia</keyword>
</DOC>